These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36453893)

  • 1. The role of magnetic resonance imaging in the diagnosis and prognosis of dementia.
    Živanović M; Aracki Trenkić A; Milošević V; Stojanov D; Mišić M; Radovanović M; Radovanović V
    Biomol Biomed; 2023 Mar; 23(2):209-224. PubMed ID: 36453893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Accuracy of MRI Visual Rating Scales in the Diagnosis of Early Onset Cognitive Impairment.
    Falgàs N; Balasa M; Bargalló N; Borrego-Écija S; Ramos-Campoy O; Fernández-Villullas G; Bosch B; Olives J; Tort-Merino A; Antonell A; Castellví M; Allen IE; Sánchez-Valle R; Lladó A
    J Alzheimers Dis; 2020; 73(4):1575-1583. PubMed ID: 31958089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic Resonance Imaging in Stable Mild Cognitive Impairment, Prodromal Alzheimer's Disease, and Prodromal Dementia with Lewy Bodies.
    Siddiqui TG; Whitfield T; Praharaju SJ; Sadiq D; Kazmi H; Ben-Joseph A; Walker Z
    Dement Geriatr Cogn Disord; 2020; 49(6):583-588. PubMed ID: 33227783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting.
    Perani D; Cerami C; Caminiti SP; Santangelo R; Coppi E; Ferrari L; Pinto P; Passerini G; Falini A; Iannaccone S; Cappa SF; Comi G; Gianolli L; Magnani G
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):499-508. PubMed ID: 26341365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of demyelination in mild cognitive impairment and dementia using a direct and specific magnetic resonance imaging measure of myelin content.
    Bouhrara M; Reiter DA; Bergeron CM; Zukley LM; Ferrucci L; Resnick SM; Spencer RG
    Alzheimers Dement; 2018 Aug; 14(8):998-1004. PubMed ID: 29679574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Biomarker Prognosis of Mild Cognitive Impairment: An 11-Year Follow-Up Study in the Alzheimer's Disease Neuroimaging Initiative.
    Spencer BE; Jennings RG; Brewer JB;
    J Alzheimers Dis; 2019; 68(4):1549-1559. PubMed ID: 30958366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Whole Picture: From Isolated to Global MRI Measures of Neurovascular and Neurodegenerative Disease.
    Dickie DA; Quinn TJ; Dawson J
    Adv Exp Med Biol; 2019; 1205():25-53. PubMed ID: 31894568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Ritchie C; Smailagic N; Noel-Storr AH; Takwoingi Y; Flicker L; Mason SE; McShane R
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD008782. PubMed ID: 24913723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of Incipient Alzheimer's Disease Dementia in Patients with Mild Cognitive Impairment.
    Ardekani BA; Bermudez E; Mubeen AM; Bachman AH;
    J Alzheimers Dis; 2017; 55(1):269-281. PubMed ID: 27662309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of (11)C-Pittsburgh compound-B positron emission tomography carried out in addition to magnetic resonance imaging and single-photon emission computed tomography on the diagnosis of Alzheimer's disease in patients with dementia and mild cognitive impairment.
    Omachi Y; Ito K; Arima K; Matsuda H; Nakata Y; Sakata M; Sato N; Nakagome K; Motohashi N
    Psychiatry Clin Neurosci; 2015 Dec; 69(12):741-51. PubMed ID: 26085054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.
    Kapoor A; Bartha R; Black SE; Borrie M; Freedman M; Gao F; Herrmann N; Mandzia J; Ozzoude M; Ramirez J; Scott CJM; Symons S; Fischer CE; Frank A; Seitz D; Wolf MU; Verhoeff NPLG; Naglie G; Reichman W; Masellis M; Mitchell SB; Tang-Wai DF; Tartaglia MC; Kumar S; Pollock BG; Rajji TK; Finger E; Pasternak SH; ; Swartz RH
    J Alzheimers Dis; 2020; 74(3):747-757. PubMed ID: 32116253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Flicker L; Bonfill Cosp X
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012884. PubMed ID: 29164602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using machine learning to quantify structural MRI neurodegeneration patterns of Alzheimer's disease into dementia score: Independent validation on 8,834 images from ADNI, AIBL, OASIS, and MIRIAD databases.
    Popuri K; Ma D; Wang L; Beg MF
    Hum Brain Mapp; 2020 Oct; 41(14):4127-4147. PubMed ID: 32614505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparametric MRI for the improved diagnostic accuracy of Alzheimer's disease and mild cognitive impairment: Research protocol of a case-control study design.
    Piersson AD; Ibrahim B; Suppiah S; Mohamad M; Hassan HA; Omar NF; Ibrahim MI; Yusoff AN; Ibrahim N; Saripan MI; Razali RM
    PLoS One; 2021; 16(9):e0252883. PubMed ID: 34547018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial Spin-Labeling Parameters and Their Associations with Risk Factors, Cerebral Small-Vessel Disease, and Etiologic Subtypes of Cognitive Impairment and Dementia.
    Gyanwali B; Tan CS; Petr J; Escobosa LLT; Vrooman H; Chen C; Mutsaerts HJ; Hilal S
    AJNR Am J Neuroradiol; 2022 Oct; 43(10):1418-1423. PubMed ID: 36562454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of positron emission tomography/magnetic resonance imaging in dementia: A literature review.
    Lorking N; Murray AD; O'Brien JT
    Int J Geriatr Psychiatry; 2021 Oct; 36(10):1501-1513. PubMed ID: 34490651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging Locus Coeruleus abnormality in amnestic Mild Cognitive Impairment is associated with future progression to dementia.
    Galgani A; Lombardo F; Martini N; Vergallo A; Bastiani L; Hampel H; Hlavata H; Baldacci F; Tognoni G; De Marchi D; Ghicopulos I; De Cori S; Biagioni F; Busceti CL; Ceravolo R; Bonuccelli U; Chiappino D; Siciliano G; Fornai F; Pavese N; Giorgi FS
    Eur J Neurol; 2023 Jan; 30(1):32-46. PubMed ID: 36086917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people.
    den Heijer T; Geerlings MI; Hoebeek FE; Hofman A; Koudstaal PJ; Breteler MM
    Arch Gen Psychiatry; 2006 Jan; 63(1):57-62. PubMed ID: 16389197
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.